Xenon Pharmaceuticals
XENE
XENE
209 hedge funds and large institutions have $2.99B invested in Xenon Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 66 increasing their positions, 69 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.24% more ownership
Funds ownership: 98.84% → 100.08% (+1.2%)
1% more capital invested
Capital invested by funds: $2.95B → $2.99B (+$41.3M)
4% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 69
Holders
209
Holding in Top 10
13
Calls
$4.36M
Puts
$82K
Top Buyers
| 1 | +$23.8M | |
| 2 | +$19.1M | |
| 3 | +$14.9M | |
| 4 |
SC
Stempoint Capital
New York
|
+$14.7M |
| 5 |
FTM
First Turn Management
Del Mar,
California
|
+$14.1M |
Top Sellers
| 1 | -$15.5M | |
| 2 | -$15.2M | |
| 3 | -$15.1M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$13.5M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$11.6M |